Hypermethylation of CpG islands in the promoter region is the major mechanism for RASSF1A gene inactivation, which has been observed in many human cancers, including nasopharyngeal cancer, colorectal cancer, breast cancer and lung cancer. Here, RASSF1 is linked to cancer.